Efficacy of second line chemotherapy following first line triplet chemotherapy in advanced colorectal cancer (ACRC)

被引：0
|
作者：
Hakoun, A. M. [1 ]
Gad, A. M. [2 ]
Alzahrani, A. [3 ]
Aljubran, A. [3 ]
Bazarbashi, S. [3 ]
机构：
[1] Alfaisal Univ, Coll Med, Res Off Dept, Riyadh, Saudi Arabia
[2] Ain Shams Univ, Fac Med, Dept Clin Oncol, Cairo, Egypt
[3] King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh, Saudi Arabia
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
194P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Second-line chemotherapy in advanced bladder cancer
    Pavone-Macaluso, M
    Sternberg, C
    UROLOGIA INTERNATIONALIS, 2000, 64 (02) : 61 - 69
  • [22] Safety and efficacy of first-line chemotherapy in unresected metastatic colorectal cancer
    Puthillath, Ajithkumar
    Dunn, Kelli Bullard
    Rajput, Ashwani
    Smith, Judy
    Yang, Gary
    Wilding, Gregory E.
    Tan, Wei
    Gupta, Bhavna
    Fakih, Marwan G.
    CLINICAL COLORECTAL CANCER, 2007, 6 (10) : 710 - 715
  • [23] Association Between Peripheral Neuropathy Induced by Oxaliplatin at First-line Chemotherapy and Efficacy of Paclitaxel at Second-line Chemotherapy in Patients With Advanced Gastric Cancer
    Fujii, Hironori
    Sadaka, Shiori
    Ajisawa, Kanae
    Okumura, Naoki
    Makiyama, Akitaka
    Iihara, Hirotoshi
    Yasufuku, Itaru
    Ohata, Koichi
    Kobayashi, Ryo
    Tanaka, Yoshihiro
    Hayashi, Hideki
    Suzuki, Akio
    ANTICANCER RESEARCH, 2022, 42 (09) : 4581 - 4588
  • [24] Risk Prediction of Myelosuppression Following First-line Chemotherapy in Colorectal Cancer
    Du, Yanyuan
    Liu, Yuming
    Fang, Ruiying
    Cai, Liu
    Song, Ying
    Ma, Susu
    Yu, Huibo
    Gao, Jin
    Zhang, Hanyue
    Li, Baihui
    Zheng, Honggang
    JOURNAL OF CANCER, 2025, 16 (04): : 1379 - 1396
  • [25] First line chemotherapy options in metastatic colorectal cancer
    Stanculeanu, D.
    Matache, R.
    Minea, L.
    Cringeanu, A.
    Anghel, R.
    ANNALS OF ONCOLOGY, 2006, 17 : 79 - 79
  • [26] The combination of capecitabine and oxaliplatine as a second-line chemotherapy in the advanced colorectal cancer patients
    Musayev, I
    Zeynalov, R.
    Giyasbeyli, S.
    Gasanzadeh, J.
    Dadashova, N.
    Ahadova, N.
    ANNALS OF ONCOLOGY, 2007, 18 : VII84 - VII84
  • [27] Irinotecan as a second line chemotherapy in advanced and metastatic colorectal cancer. Is that appropriate regimen?
    Chilikidi, KY
    Lazarev, AF
    Doty, IN
    CLINICAL CANCER RESEARCH, 1999, 5 : 3775S - 3775S
  • [28] Value of SMAD4 in patients with advanced colorectal cancer (aCRC) receiving an oxaliplatin containing first line chemotherapy - a study of the AIO colorectal cancer group (AIO)
    Munding, J.
    Baraniskin, A.
    Meier, D.
    Porschen, R.
    Arkenau, H.
    Graeven, U.
    Schulmann, K.
    Schmiegel, W.
    Tannapfel, A.
    Reinacher-Schick, A.
    ONKOLOGIE, 2010, 33 : 71 - 72
  • [29] Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer
    Otsuka, Ryo
    Iwasa, Satoru
    Yanai, Takako
    Hirano, Hidekazu
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Hashimoto, Hironobu
    Sekiguchi, Masatoshi
    Makino, Yoshinori
    Boku, Narikazu
    Yamaguchi, Masakazu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (04) : 595 - 601
  • [30] First line chemotherapy of advanced epithelial ovarian cancer
    Lhomme, C.
    Even, C.
    Morice, P.
    Balleyguier, C.
    Petrella, M. C.
    Gouy, S.
    Uzan, C.
    Duvillard, P.
    Pautier, P.
    BULLETIN DU CANCER, 2009, 96 (12) : 1207 - 1213
12345